ETHZ
Price
$5.13
Change
-$0.22 (-4.11%)
Updated
Dec 24 closing price
Capitalization
97.14M
Intraday BUY SELL Signals
PRQR
Price
$2.17
Change
-$0.04 (-1.81%)
Updated
Dec 24 closing price
Capitalization
228.6M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETHZ vs PRQR

Header iconETHZ vs PRQR Comparison
Open Charts ETHZ vs PRQRBanner chart's image
ETHZilla
Price$5.13
Change-$0.22 (-4.11%)
Volume$402.98K
Capitalization97.14M
ProQR Therapeutics
Price$2.17
Change-$0.04 (-1.81%)
Volume$144.81K
Capitalization228.6M
ETHZ vs PRQR Comparison Chart in %
ETHZ
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ETHZ vs. PRQR commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETHZ is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (ETHZ: $5.13 vs. PRQR: $2.17)
Brand notoriety: ETHZ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETHZ: 31% vs. PRQR: 29%
Market capitalization -- ETHZ: $97.14M vs. PRQR: $228.6M
ETHZ [@Biotechnology] is valued at $97.14M. PRQR’s [@Biotechnology] market capitalization is $228.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETHZ’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ETHZ’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, PRQR is a better buy in the long-term than ETHZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETHZ’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • ETHZ’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ETHZ and PRQR are a bad buy in the short-term.

Price Growth

ETHZ (@Biotechnology) experienced а -21.44% price change this week, while PRQR (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($229M) has a higher market cap than ETHZ($97.1M). PRQR YTD gains are higher at: -18.113 vs. ETHZ (-71.813). PRQR has higher annual earnings (EBITDA): -38.15M vs. ETHZ (-216.47M). PRQR has more cash in the bank: 107M vs. ETHZ (53.3M). PRQR has less debt than ETHZ: PRQR (16.5M) vs ETHZ (547M). PRQR has higher revenues than ETHZ: PRQR (15.5M) vs ETHZ (4.11M).
ETHZPRQRETHZ / PRQR
Capitalization97.1M229M42%
EBITDA-216.47M-38.15M567%
Gain YTD-71.813-18.113396%
P/E RatioN/AN/A-
Revenue4.11M15.5M27%
Total Cash53.3M107M50%
Total Debt547M16.5M3,315%
FUNDAMENTALS RATINGS
ETHZ vs PRQR: Fundamental Ratings
ETHZ
PRQR
OUTLOOK RATING
1..100
5377
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9753
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (30) in the Biotechnology industry is in the same range as ETHZ (41) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's SMR Rating (99) in the Biotechnology industry is in the same range as ETHZ (99) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's Price Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for ETHZ (97) in the Financial Conglomerates industry. This means that PRQR’s stock grew somewhat faster than ETHZ’s over the last 12 months.

ETHZ's P/E Growth Rating (96) in the Financial Conglomerates industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ETHZ’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETHZPRQR
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
88%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ETHZ
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNSAF4.260.02
+0.38%
Mineros S.A.
HWDJF10.97N/A
N/A
Howden Joinery Group Plc
SYZLF4.05N/A
N/A
Sylogist Ltd.
SWDBF34.77N/A
N/A
Swedbank AB
FOFA0.26N/A
N/A
Family Office of America Inc.

ETHZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETHZ has been loosely correlated with JSPR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ETHZ jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETHZ
1D Price
Change %
ETHZ100%
-4.11%
JSPR - ETHZ
41%
Loosely correlated
+1.10%
PRQR - ETHZ
38%
Loosely correlated
-1.81%
REPL - ETHZ
34%
Loosely correlated
+3.81%
ANRO - ETHZ
34%
Loosely correlated
+1.12%
WVE - ETHZ
32%
Poorly correlated
+4.41%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-1.81%
BEAM - PRQR
49%
Loosely correlated
+1.33%
RGNX - PRQR
48%
Loosely correlated
+0.77%
ETHZ - PRQR
44%
Loosely correlated
-4.11%
DNLI - PRQR
44%
Loosely correlated
+1.07%
SYRE - PRQR
43%
Loosely correlated
-0.54%
More